High‐resolution metabolomic profiling of Alzheimer’s disease in plasma
Abstract Background Alzheimer’s disease (AD) is a complex neurological disorder with contributions from genetic and environmental factors. High‐resolution metabolomics (HRM) has the potential to identify novel endogenous and environmental factors involved in AD. Previous metabolomics studies have id...
Main Authors: | Megan M. Niedzwiecki, Douglas I. Walker, Jennifer Christina Howell, Kelly D. Watts, Dean P. Jones, Gary W. Miller, William T. Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.50956 |
Similar Items
-
High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases
by: Douglas I. Walker, et al.
Published: (2022-05-01) -
Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
by: Anurag Mehta, et al.
Published: (2020-01-01) -
High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
by: Jeffrey M Collins, et al.
Published: (2018-01-01) -
Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer’s disease and mild cognitive impairment
by: Andreas Giannisis, et al.
Published: (2023-07-01) -
Correction: Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer’s disease and mild cognitive impairment
by: Andreas Giannisis, et al.
Published: (2023-09-01)